The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $65.48

Today's change+0.09 +0.14%
Updated February 21 4:00 PM EST. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $65.48

Today's change+0.09 +0.14%
Updated February 21 4:00 PM EST. Delayed by at least 15 minutes.

Merck & Co Inc up (U.S.)$0.09

Merck & Co Inc closed up Tuesday by (U.S.)$0.09 or 0.14% to (U.S.)$65.48. Shares have lost 0.27% over the last five days, but have gained 11.23% over the last year to date. This security has outperformed the S&P 500 by 7.31% during the last year.

Key company metrics

  • Open(U.S.) $64.90
  • Previous close(U.S.) $65.39
  • High(U.S.) $65.78
  • Low(U.S.) $64.90
  • Bid / Ask(U.S.) $65.07 / (U.S.) $65.47
  • YTD % change+11.23%
  • Volume7,386,072
  • Average volume (10-day)9,301,497
  • Average volume (1-month)12,079,412
  • Average volume (3-month)11,179,269
  • 52-week range(U.S.) $49.63 to (U.S.) $65.87
  • Beta0.82
  • Trailing P/E32.06×
  • P/E 1 year forward17.12×
  • Forward PEG2.70×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.87%
  • Trailing EPS(U.S.) $2.04
Updated February 21 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.53%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue10,11510,5369,8449,312
Total other revenue--------
Total revenue10,11510,5369,8449,312
Gross profit6,7837,1636,3325,787
Total cost of revenue3,3323,3733,5123,525
Total operating expense7,9107,6278,3217,640
Selling / general / administrative2,5932,3562,3532,313
Research & development1,7201,6502,0871,604
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)265248369198
Other operating expenses, total--------
Operating income2,2052,9091,5231,672
Interest income (expense), net non-operating---170-171-172
Gain (loss) on sale of assets--------
Other--------
Income before tax1,4842,8871,5041,624
Income after tax1,1842,1881,2091,130
Income tax, total300699295494
Net income1,1772,1841,2051,125
Total adjustments to net income--------
Net income before extra. items1,1772,1841,2051,125
Minority interest-7-4-4-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,1772,1841,2051,125
Inc. avail. to common incl. extra. items1,1772,1841,2051,125
Diluted net income1,1772,1841,2051,125
Dilution adjustment--------
Diluted weighted average shares2,7762,7862,7892,795
Diluted EPS excluding extraordinary itemsvalue per share0.420.780.430.40
Dividends per sharevalue per share0.460.460.460.46
Diluted normalized EPSvalue per share0.500.850.540.45